Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 165 clinical trials
featured
Men with Metastatic Prostate Cancer

Men with metastatic prostate cancer are asked to participate in a research study being conducted by Montefiore Medical Center.  

  • 14 views
  • 09 Jan, 2020
  • 1 location
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer

This randomized phase II trial studies how well surgical removal of the prostate and antiandrogen therapy with or without docetaxel work in treating men with newly diagnosed prostate cancer that has spread to other places in the body. Androgens can cause the growth of prostate cancer cells. Antiandrogen therapy may …

  • 22 views
  • 08 Oct, 2020
  • 15 locations
PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer

Patients with metastatic prostate cancer can undergo MRI-guided prostate Stereotactic body radiation therapy (SBRT) without significant adverse events, similar to what has been reported for

adenocarcinoma of prostate
stereotactic body radiation therapy
adenocarcinoma
MRI
  • 1 views
  • 25 Oct, 2020
  • 1 location
PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study

locally metastatic prostate cancer at the time of diagnosis. Patients will undergo a single PSMA-PET/MRI (or PET/CT (Computed Tomography) in some circumstances) prior to initiation of treatment. Following

pet/ct scan
positron emission tomography
MRI
ct scan
adenocarcinoma of prostate
  • 0 views
  • 28 Sep, 2020
  • 1 location
Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy

Prostate cancer is the first cancer in men. The treatment of metastatic prostate cancer with chemotherapy is based on the intravenous administration of docetaxel chemotherapy. Symptoms of

  • 0 views
  • 11 Oct, 2020
  • 1 location
Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer

This study will assess the impact of the novel oral hormonal agents (abiraterone acetate or enzalutamide) among elderly metastatic prostate cancer patients. This study will assess the influence

  • 1 views
  • 22 Jan, 2021
  • 7 locations
Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1/2 dose escalation study to assess the safety and tolerability of ARV-110 in men with mCRPC who have progressed on prior approved systemic therapies for their castrate resistant disease (one of which must be enzalutamide or abiraterone).

gonadotropin
medical castration
adenocarcinoma
castration-resistant prostate cancer
metastatic castration-resistant prostate cancer
  • 83 views
  • 24 Sep, 2020
  • 5 locations
Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide

Prostate cancer (PCa) is the most frequently diagnosed cancer in Canadian men. While the majority of PCa is slow growing and responds well to first line treatment, a proportion of cases (10%) progress to metastatic form resulting in more than 4 000 deaths annually in Canada and 250 000 worldwide. …

measurable disease
cabazitaxel
bone lesion
androgen ablation
metastatic castration-resistant prostate cancer
  • 4 views
  • 24 Jan, 2021
  • 3 locations
A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

This study will test the safety and efficacy of FOR46 given every 21 days to patients with metastatic castration-resistant prostate cancer. The name of the study drug involved in this study is: FOR46 for Injection (FOR46)

gonadotropin
antiandrogens
testosterone
castration-resistant prostate cancer
luteinizing hormone
  • 11 views
  • 24 Sep, 2020
  • 6 locations
Radium-223 and Radiotherapy in Hormone-Na ve Men With Oligometastatic Prostate Cancer to Bone

This is a phase IIa, open label, single arm, and prospective study of hormone therapy-nave men with oligometastatic prostate cancer to the bone. The study will test if treating the primary tumor sites and 5 or fewer sites of bone-only metastasis with external beam radiation with concomitant systemic Radium-223 will …

  • 3 views
  • 19 Jan, 2021
  • 1 location